2009 Biosimilars Drug Development 
PharmaTech
JUNE 24, 2025
The LNP-encapsulated small interfering RNA (siRNA) was approved by FDA for the treatment of hereditary transthyretin amyloidosis (ATTR), and this opened the door for mRNA-based drugs in many applications. Top 8 mRNA Vaccines and Therapeutics Companies.
pharmaphorum
JUNE 30, 2025
Can you give a brief overview of why the historical development of new treatments for neurodevelopmental disorders has faced significant challenges? With the right teams and experience in place, drug developers can unlock their full potential, streamline efforts to advance them quickly, and bring more, new options to patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 2, 2025
The ability to streamline clinical trials, personalise treatments, and accelerate drug development is groundbreaking. A recent report found that 64% of pharmaceutical executives are hesitant to integrate AI into drug development due to concerns over security. The opportunity ahead is enormous.
pharmaphorum
JUNE 17, 2025
If completed, it will be Lillys third major acquisition in 2025, coming after it agreed to buy cancer drug developer Scorpion Therapeutics for up to $2.5 R&D Deep Dive: Research and Development 2025 Every breakthrough in medicine, every new treatment that changes lives, starts with research.
pharmaphorum
JUNE 27, 2025
R&D Deep Dive: Research and Development 2025 Every breakthrough in medicine, every new treatment that changes lives, starts with research. R&D Life Sciences Industry Report - Biologics and Generics The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
pharmaphorum
JUNE 17, 2025
Its precision medicine approach – directed mainly at cancer – is being deployed in the development of tools for detection, diagnosis, monitoring, therapy selection, and drug development, driven by genomic data, clinical data, digitised medical images, and tissue samples. pharmaphorum – an EVERSANA company
pharmaphorum
JULY 17, 2025
The 7th Inflammasome Therapeutics Summit is your go-to forum for drug developers, translational scientists, and immunology innovators striving to push inflammasome-targeted therapies from concept to clinic. If you are serious about leading the charge in inflammasome drug development, this is where the future takes shape.
Expert insights. Personalized for you.
59 
Let's personalize your content